Disclaimer: The analyst forecasts below are calculated by First Call based on the projections made by the analysts who cover Haemonetics Corporation. Please note that any opinions, estimates or forecasts regarding Haemonetics Corporation’s performance made by these analysts, including their average estimate numbers, are theirs alone and do not represent opinions, forecasts or predictions of Haemonetics Corporation or its management. Haemonetics Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Our actual earnings may differ materially from those below, and our earnings are subject to risks and uncertainties such as those described in Haemonetics Corporation’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.
|Data Provided by Thomson Reuters|